By vgreene, 22 February, 2021 Every visit reinforce self monitoring sx or peak flow action plan inhaler device technique quick relief vs controller meds med adherence environment control
By vgreene, 22 February, 2021 May use FeNO as part of monitoring w hx clinical findings spirometry in pts w persistent allergic asthma
By vgreene, 22 February, 2021 F U q2 6wk to achieve control then q1 6mo to monitor control q3mo if step down tx anticipated
By vgreene, 22 February, 2021 Every visit reinforce self monitoring sx or peak flow action plan inhaler device technique quick relief vs controller meds med adherence environment control
By vgreene, 22 February, 2021 May use FeNO as part of monitoring w hx clinical findings spirometry in pts w persistent allergic asthma
By vgreene, 22 February, 2021 May use FeNO as part of monitoring w hx clinical findings spirometry in pts w persistent allergic asthma
